The National Institutes of Health has awarded one-year supplemental grants totaling $1.67 million to five institutions to explore potential links between COVID-19 vaccination and menstrual changes. Some women have reported experiencing irregular or missing menstrual periods, bleeding that is heavier than usual, and other menstrual changes after receiving COVID-19 vaccines. The new awards support research to determine whether such changes may be linked to COVID-19 vaccination itself and how long the changes last. Researchers also will seek to clarify the mechanisms underlying potential vaccine-related menstrual changes.
Stacey Missmer is a professor of obstetrics, gynecology and reproductive biology in the Michigan State University College of Human Medicine. Her current research study, Women’s Outcomes Research and Knowledge, or WORK, is focused on diagnosing and treating pelvic pain in women and girls.
Missmer will be presenting her research, Reproductive Health Science: Multidisciplinary Discovery and Community Engagement, at the Board of Trustees meeting on June 18.
Richard Leach, a national expert on in vitro fertilization and an academic researcher in the Michigan State University College of Human Medicine, has been appointed chair of the Henry Ford Medical Group’s Department of Women’s Health Services. Leach will serve in a dual role and continue as chair of the Department of Obstetrics, Gynecology and Reproductive Biology for MSU’s College of Human Medicine.
Medical researchers have long known of a link between endometriosis and infertility in women, but precisely how the two are related remains unknown.
But now a team that includes Michigan State University researchers, backed by a federal grant, hopes to solve that mystery and find possible treatments.
“There is a strong relationship between endometriosis and infertility,” said Jae-Wook Jeong, PhD, a principal investigator for the study and a Michigan State University College of Human Medicine professor of Obstetrics, Gynecology and Reproductive Biology.
Congradulations to Jackie Luthardt, MD candidate 2021, who is this year’s recipient of the Bruce Drukker Endowed Award of Excellence in Obstetrics and Gynecology. Jackie is a Upper Peninsula campus CHM student who is pursuing a career in Ob/Gyn. Her residency Match was to the prestigious University of Wisconsin where she will train in their Rural Track beginning this summer.
During her 3rd year as a medical student, Jackie was nominated by her peers and inducted into the Gold Humanism Honor Society. A member of the National Ski Patrol, she has developed skills to provide medical care in settings from rural communities to the wilderness to the slopes, completing both the CHM Leadership in Rural Medicine certificate program and Outdoor Emergency Care Technician training. She served as Junior Editor of the Medical Student Research Journal and contributed to a research project on prenatal substance use. Jackie was selected to represent her medical school peers in multiple leadership and community outreach roles.
We are proud to honor Jackie with the 2021 Bruce Drukker Endowed Award of Excellence.
College of Human Medicine researchers have received a National Institutes of Health grant to study the connection between a gene important for normal cell survival and endometriosis, a painful disease which affects one in 10 women of reproductive age. The disease also has a significant economic impact, estimated at $95 billion annually in the U.S. in lost wages and medical expenses.
The gene called NOTCH1 is “needed for normal reproduction, but when it goes awry it has a significant role in endometriosis,” said Asgi Fazleabas, PhD, a University Distinguished Professor of Obstetrics, Gynecology and Reproductive Biology.
Dr. Field is a nationally recognized gynecologic oncologist. He brings more than 15 years of oncology experience to Mid-Michigan. Dr. Field specializes in minimally invasive surgery, open debulking of ovarian cancer, chemotherapy, and hormone therapy treatments for women with gynecologic cancers, including ovarian and endometrial cancer. Since 2012, he has served as principal investigator for Gynecologic Oncology Group, NRG Oncology Clinical Trials, which is responsible for improving and expanding cancer diagnosis and treatment. He is assistant professor and director of the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology, and Reproductive Biology in the College of Human Medicine at Michigan State University.